Innova Captab Limited (NSE:INNOVACAP)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018
Drugs and Pharmaceutical Products	16.30B	12.44B	10.81B	9.26B	8.01B
Drugs and Pharmaceutical Products Growth	31.06%	15.02%	16.72%	15.72%	94.94%
Total	16.30B	12.44B	10.81B	9.26B	8.01B
Total Growth	31.06%	15.02%	16.72%	15.72%	94.94%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018
India	9.79B	8.04B	8.32B	8.45B	7.23B
India Growth	21.75%	-3.43%	-1.47%	16.84%	95.52%
outside India	2.98B	1.48B	2.45B	806.63M	767.81M
outside India Growth	100.86%	-39.42%	203.29%	5.06%	92.96%
Total	12.76B	9.52B	10.77B	9.25B	8.00B
Total Growth	34.07%	-11.61%	16.38%	15.71%	95.27%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 18, 2026

Data Sources Report a data error